ELUTElutia Inc - Ordinary Shares - Class A
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women’s Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women’s Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Gaithersburg, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
51
Frequently Asked Questions
What is Market Cap of Elutia Inc - Ordinary Shares - Class A?
What is the 52-week high for Elutia Inc - Ordinary Shares - Class A?
What is the 52-week low for Elutia Inc - Ordinary Shares - Class A?
What is Elutia Inc - Ordinary Shares - Class A stock price today?
What was Elutia Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Elutia Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Elutia Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Elutia Inc - Ordinary Shares - Class A?
How many employess does Elutia Inc - Ordinary Shares - Class A has?